Company intelligence / Profile preview

SymBiosis Capital Management

Bentonville, Arkansas, United States

Ownership: Private
Development stage: Other

Overview

SymBiosis Capital Management is a venture capital firm investing in private companies with programs in or about to enter human trials. They typically deploy $5-15M initially per investment and focus on novel biologics, cell therapies, gene therapies, and precision small molecules across various serious disease therapeutic areas.

Modalities: novel biologicscell therapiesgene therapiesprecision small molecules
Industry: Investors

Partnerships

HealthTech Arkansas

Beyond the preview

Go deeper on SymBiosis Capital Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SymBiosis Capital Management.

Explore the full profile